Approval of Opdivo plus Yervoy combination was based on results from the Phase III CheckMate-9DW trial, which demonstrated ...

Researchers sought to test the performance of a deep learning model system using longitudinal magnetic resonance imaging (MRI) in predicting early recurrence in patients with hepatocellular carcinoma.

The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.

Donald Trump has suffered a skin cancer scare following his latest medical report after doctors found "benign lesions" ...

The following is a summary of "Novel devices and biomarkers in screening for esophageal squamous cell cancer," published in ...

Teddi Mellencamp, who is battling stage four melanoma, revealed that her doctors have given her 50/50 odds of beating her ...

Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...

Merkel cell carcinoma (MCC) is a rare type of skin cancer. It starts in the Merkel cells, which are usually in the top layer of the skin. This layer is called the epidermis. Merkel cells are near the ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

The US Food and Drug Administration (FDA) has granted approval for Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) in ...

Influencer Sidney Raz shared that he has been diagnosed with stomach cancer nearly seven months after his daughter died in ...

Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of ...